title: Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus.
abstract: BACKGROUND
  Circulating concentrations of heme oxygenase-1 (HO-1) have been recently reported to be elevated in several chronic disorders. However, no study has ever examined the association between circulating HO-1 concentrations and type 2 diabetes mellitus (T2DM).
  
  
  RESULTS
  581 cases with newly-diagnosed T2DM (New-T2DM) and 611 comparison controls were recruited in this two-phase case-control study, comprising 420 cases and 429 controls collected in the first phase study and 161 cases and 182 controls in the second phase replication study. Analyses, using both separated data and combined data from the two-phase studies, show that plasma HO-1 concentrations were significantly increased in New-T2DM cases compared to controls (P<0.001). Plasma HO-1 concentrations were significantly correlated with plasma glucose concentrations, HOMA-beta and HOMA-IR (P<0.001). After adjustment for age, sex, BMI and family history of diabetes, the ORs for New-T2DM in the highest quartile of plasma HO-1 concentrations, compared with the lowest, was 8.23 (95% CI 5.55-12.21; P for trend <0.001). The trend remained significant after additional adjustment for fasting plasma glucose/insulin, HOMA-beta/HOMA-IR, TC/TG, smoking, drinking and history of hypertension, and even in further stratification analysis by age, sex, BMI, smoking, drinking and history of hypertension.
  
  
  CONCLUSIONS
  Elevated plasma HO-1 concentrations are associated with higher ORs for New-T2DM, which add more knowledge regarding the important role of oxidative stress in T2DM. More consequent studies were warranted to confirm the clinical utility of plasma HO-1, especially in diagnosis and prognosis of T2DM and its complications.
authors.affiliation: Department of Nutrition and Food Hygiene and MOE Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
authors.forename: Wei
authors.initials: W
authors.lastname: Bao
authors.forename: Fangfang
authors.initials: F
authors.lastname: Song
authors.forename: Xiangyang
authors.initials: X
authors.lastname: Li
authors.forename: Shuang
authors.initials: S
authors.lastname: Rong
authors.forename: Wei
authors.initials: W
authors.lastname: Yang
authors.forename: Muxun
authors.initials: M
authors.lastname: Zhang
authors.forename: Ping
authors.initials: P
authors.lastname: Yao
authors.forename: Liping
authors.initials: L
authors.lastname: Hao
authors.forename: Nianhong
authors.initials: N
authors.lastname: Yang
authors.forename: Frank B
authors.initials: FB
authors.lastname: Hu
authors.forename: Liegang
authors.initials: L
authors.lastname: Liu
mesh_terms: D000367:Age Factors; D000704:Analysis of Variance; D015992:Body Mass Index; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000175:diagnosis / Q000201:enzymology* / Q000503:physiopathology; D005260:Female; D051547:Heme Oxygenase-1 / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012737:Sex Factors
chemical_list: C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1
references.citation: Int J Hematol. 2010 Mar;91(2):229-37
references.pmid: 20091384
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30
references.pmid: 9380736
references.citation: Pharmacol Rev. 2008 Mar;60(1):79-127
references.pmid: 18323402
references.citation: J Allergy Clin Immunol. 2008 Aug;122(2):290-7, 297.e1-8
references.pmid: 18582925
references.citation: Am J Respir Crit Care Med. 2006 Oct 15;174(8):906-14
references.pmid: 16858012
references.citation: Am J Epidemiol. 2009 Sep 15;170(6):747-56
references.pmid: 19696228
references.citation: Physiol Rev. 2006 Apr;86(2):583-650
references.pmid: 16601269
references.citation: Neurology. 2000 Mar 28;54(6):1297-304
references.pmid: 10746601
references.citation: J Biol Chem. 2003 Jan 31;278(5):2997-3005
references.pmid: 12438314
references.citation: Diabetologia. 2003 Sep;46(9):1234-44
references.pmid: 12898011
references.citation: Biomed Environ Sci. 2002 Mar;15(1):83-96
references.pmid: 12046553
references.citation: Am J Respir Cell Mol Biol. 2002 Jul;27(1):8-16
references.pmid: 12091240
references.citation: Nat Med. 1998 Dec;4(12):1364-5
references.pmid: 9846569
references.citation: J Clin Invest. 1999 Jan;103(1):129-35
references.pmid: 9884342
references.citation: Eur J Nutr. 2007 Mar;46(2):61-9
references.pmid: 17278042
references.citation: Endocr Rev. 2008 May;29(3):351-66
references.pmid: 18048763
references.citation: Cell Stress Chaperones. 2007 Winter;12(4):299-306
references.pmid: 18229449
references.citation: Diabetes. 1997 Nov;46(11):1733-42
references.pmid: 9356019
references.citation: Diabet Med. 2006 Jun;23(6):666-74
references.pmid: 16759310
references.citation: Endocr Rev. 2002 Oct;23(5):599-622
references.pmid: 12372842
references.citation: Antioxid Redox Signal. 2007 Mar;9(3):355-66
references.pmid: 17184181
references.citation: Diabetes. 2003 Jan;52(1):1-8
references.pmid: 12502486
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10919-24
references.pmid: 9380735
references.citation: JAMA. 2006 Apr 12;295(14):1681-7
references.pmid: 16609090
references.citation: Clin Sci (Lond). 2007 Jun;112(12):599-606
references.pmid: 17209802
references.citation: Acta Neurol Scand. 2010 Feb;121(2):136-8
references.pmid: 19785642
references.citation: J Clin Endocrinol Metab. 2003 Apr;88(4):1753-9
references.pmid: 12679469
references.citation: Diabet Med. 1998 Jul;15(7):539-53
references.pmid: 9686693
references.citation: Free Radic Biol Med. 2004 Dec 15;37(12):1995-2011
references.pmid: 15544918
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: J Korean Med Sci. 2006 Jun;21(3):418-24
references.pmid: 16778382
references.citation: Diabetes. 2003 Sep;52(9):2338-45
references.pmid: 12941774